In an attempt to takeover the European junk bonds after the financial crisis, Nycomed, one of the private equity-owned Swiss drugmaker has made a 4.5 billion Euros bid to purchase Solvay SA’s drug operations. The Zurich based company said that it this bid and takeover is finalized it will help them to reach their annual sales figures of $6 million which is why they have gone ahead and made such a high bid to buy Solvay’s pharmaceutical unit and operations. However, the Belgian conglomerate Solvay SA’s has not yet responded to the bid and has informed that they might take a little time to think about it and would not rush through the deal....

• Red Hat (NYSE:RHT) reported fiscal second quarter results of 20 cents a share, compared with Zacks estimates of 11 cents a share, on revenues of $183.6 million, versus estimates of $179.0 million

• Deutsche Bank (NYSE:DB) cut AutoZone (NYSE:AZO) price target to $150 from $175 but maintained its “hold" rating on the stock

• Reports say modifications on the Boeing (NYSE:BA) 787 Dreamliner test plane suggest the first flight is possible by late October or early November

• The corporate head of Microsoft's (NASDAQ:MSFT) Game Studios division ruled out plans to acquire video game publisher Electronics Arts (NASDAQ:ERTS)

• Abbott Laboratories (NYSE:ABT) has offered to buy the drug unit of Belgian's conglomerate Solvay SA

• Deutsche Bank (NYSE:DB) raised its price target for HB Fuller (NYSE:FUL) to $23 from $18, while maintaining its "hold" rating

• Goldman Sachs (NYSE:GS) raised its price target on Buffalo Wild Wings (NASDAQ:BWLD) to $46

• Nintendo lowered its Wii price

...

On Friday, the U.S. Food and Drug Administration (FDA) approved Eurand N.V.'s (EURX) New Drug Application for its pancreatic enzyme product (PEP) Zenpep. The product targets a condition where insufficient secretion of enzymes by the pancreas hampers digestion of food. This phenomenon, known as exocrine pancreatic insufficiency (EPI), causes malnutrition, impaired growth in children, compromised immune response and shortened life expectancy.   EPI is very common in cystic fibrosis patients. Cystic fibrosis causes life-threatening lung infections and serious digestive complications. Zenpep, which improves digestion and absorption by replacing the missing enzymes, is the only FDA-approved PEP to be tested in adults and children below 12 years of age. The approval of Zenpep is a major milestone for EPI patients. The drug would enable doctors to fine tune treatment regimens to achieve optimal symptom control with improved dosing precision thereby reducing pill burden.   Previously, PEPs were not regulated and

...

Investors occasionally use a stock trading technique called 'Buying Dividends,' which is the technique of buying stocks before the ex dividend date and selling the stock shortly after the ex date at about the same price, yet still being entitled to the dividend. This technique generally works only in bull markets.br /br /If you are interested in a href="http://stockerblog.blogspot.com/2008/05/buying-dividends-top-7-stocks-going-ex.html"buying dividends/a, there are many stocks in many different industries to choose from. In order to be entitled to the dividend, you have to buy the stock before the ex-dividend date, and you can't sell the stock until after the ex date. The actual dividend may not be paid for another few weeks.br /br /All of the following stocks have market caps over $500 million, and yield over 1%. br /br /Repsol YPF, S.A. ( REP) Ex-dividend date: 1/12/2009 Yield: 7.55%br /Solvay S.A. (SVYSY) Ex-dividend date: 1/12/2009 Yield: 7.51%br /Abbott Laboratories (ABT) ...